CompanyAuto-indexed · Unverified
Iambic Therapeutics, Inc.
SAN DIEGO, US SEC EDGAR
Every public capital-raising filing we've indexed for this company, over time. Compiled automatically from public sources — not verified by the company.
Filings
6
Total reported raised
$288.1M
People named
14
First indexed
2026
Funding history (6)
Sep 9, 2026Company raise· Biotechnology
Iambic Therapeutics, Inc. raised $66.0M
Raised
$66.0M
Apr 8, 2026Company raise· Biotechnology
Iambic Therapeutics, Inc. raised $27.8M
Raised
$27.8M
Nov 21, 2025Company raise· Biotechnology
Iambic Therapeutics, Inc. raised $99.3M
Raised
$99.3M
Jun 6, 2024Company raise· Biotechnology
Iambic Therapeutics, Inc. raised $38.4M
Raised
$38.4M
May 7, 2024Company raise· Biotechnology
Iambic Therapeutics, Inc. raised $29.9M
Raised
$29.9M
Apr 25, 2024Company raise· Biotechnology
Iambic Therapeutics, Inc. raised $26.9M
Raised
$26.9M
People named on filings
Evan Rachlin · DirectorFred Manby · DirectorJishnu Bhattacharjee · DirectorKurt von Emster · DirectorMary Tagliaferri · DirectorMichael Secora · Executive OfficerNeil Josephson · Executive OfficerPete Olson · Executive OfficerR. Jacob Vogelstein · DirectorSamit Hirawat · DirectorShalini Sharp · DirectorTabbert Teng · Executive OfficerThomas Miller · DirectorWilliam Rastetter · Director